Janssen Vaccines & Prevention B.V.

Leiden, ZH Doing business as JPC

UEI
VRE2EKNJTJJ4
CAGE
H1N64
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Archimedesweg 4, 2333 CN Leiden, Netherlands
Website
jnj.com
Founded
1886
Employees
100K+
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 -$620,809
FY2023 $4,264,862

Contract awards

Award Agency Obligated Awarded
Perform the phase 3 HPX3002/ hvtn 706/ mosaico pivotal efficacy study W81XWH209C001 Medical Command (Army) $17,972,837
The purpose of this modification is to update the key personnel under section g contract administration article g.4 key… HHSO100201700013C Office of the Assistant Secretary for Preparedness and Response $132,282,550
No cost modification to closeout the contract in its entirety. HHSO100201500008C Office of the Assistant Secretary for Preparedness and Response $48,930,332
Biomedical (basic) HHSN272200900060C National Institute of Allergy and Infectious Diseases (NIH) $48,585,370
Patent prosecution of inventions W81XWH09P0394 Medical Command (Army) $11,881

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Janssen Vaccines & Prevention B.V. registered in SAM.gov?

Yes. Janssen Vaccines & Prevention B.V.'s SAM.gov registration is active through November 12, 2026.

How much has Janssen Vaccines & Prevention B.V. received in federal contracts?

Federal contracts obligated $3,644,053 to Janssen Vaccines & Prevention B.V. in fiscal years 2023 through 2027.

What is Janssen Vaccines & Prevention B.V.'s most recent federal award?

Janssen Vaccines & Prevention B.V.'s most recent federal contract award is Perform the phase 3 HPX3002/ hvtn 706/ mosaico pivotal efficacy study (W81XWH209C001), from Medical Command (Army), on January 28, 2020.

On GovTribe

See Janssen Vaccines & Prevention B.V.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login